Close
  Indian J Med Microbiol
 

Figure 2: Benefits of aspirin for the primary prevention of cardiovascular events in adults aged >40 years in the updated systematic review of 11 trials for US Preventive Services Task Force – adapted from Guirguis et al.[12] (Elderly patients had greater relative reduction in myocardial infarction; lower aspirin doses (<100 mg/d) produced greater reduction (14%) in nonfatal stroke; MI: Myocardial infarction)

Figure 2: Benefits of aspirin for the primary prevention of cardiovascular events in adults aged >40 years in the updated systematic review of 11 trials for US Preventive Services Task Force – adapted from Guirguis <b>et al</b>.<sup>[12]</sup> (Elderly patients had greater relative reduction in myocardial infarction; lower aspirin doses (<100 mg/d) produced greater reduction (14%) in nonfatal stroke; MI: Myocardial infarction)